A case report highlights a possible interaction between the gut-selective antibiotic rifaximin and carvedilol, leading to transient indirect hyperbilirubinemia. This finding may have implications for patient management in those receiving these medications.
possible interaction of the gut selective antibiotic rifaximin with carvedilol associated with transient indirect hyperbilirubinemia a case report
Original title: “Possible Interaction of the Gut-selective Antibiotic Rifaximin with Carvedilol Associated with Transient Indirect Hyperbilirubinemia: A Case Report.”